Children's Hospital and Research Institute, Marien-Hospital Wesel gGmbH, Wesel, Germany.
Pediatr Pulmonol. 2010 Mar;45(3):301-6. doi: 10.1002/ppul.21180.
Multiple breath washout (MBW) for measuring the lung clearance index (LCI) has been proposed as a non-invasive tool for detecting early cystic fibrosis (CF) lung disease. The LCI is highly repeatable and reproducible in healthy subjects. In patients with CF, within-test variability is low. However, application of physiotherapy (PT) immediately preceding MBW may affect LCI variability in CF patients and thus interpretation of repeat measurements and treatment effects. Therefore, the aim of the present study was to prospectively assess the short-term effect of PT on LCI in CF patients in order to address the question whether or not standardized timing of PT and MBW has to be considered when introducing MBW into clinical CF management. Twenty-seven out of 32 patients (5.7-15.9 years) with CF successfully performed two technically acceptable MBW tests with the EasyOne Pro, MBW Module (ndd, Switzerland) at intervals of 1(1/2) hr. Sixteen out of 27 received 30 min PT in between, whereas 11/27 did not.Repeatability expressed as intraindividual coefficient of variation (CV) was 6.1% pre-PT and 6.5% post-PT. Mean difference (95% CI) of LCI between the two tests was -0.20 (-0.51; 0.11). Reproducibility (SD) was 4.6% (3.1). Repeatability was 4.2% and 7.1% without intervention. Mean difference (95% CI) of LCI between 1st and 2nd test was 0.07 (-0.22; 0.35). Reproducibility (SD) was 2.6% (2.1).In conclusion, PT does not have a consistent effect on the LCI. Repeatability was slightly poorer than published for healthy subjects possibly reflecting variable mucus plugging, and, thus, variable trapped air in patients with CF. Reproducibility was good and independent on intervention. From our data, we conclude that timing of PT in relation to MBW can be ignored when designing study protocols or when interpreting longitudinal data and treatment effects.
多次呼吸冲洗(MBW)用于测量肺清除指数(LCI),已被提议作为一种非侵入性工具,用于检测早期囊性纤维化(CF)肺部疾病。LCI 在健康受试者中具有高度可重复性和再现性。在 CF 患者中,测试内变异性较低。然而,MBW 之前进行的物理治疗(PT)可能会影响 CF 患者的 LCI 变异性,从而影响重复测量和治疗效果的解释。因此,本研究的目的是前瞻性评估 PT 对 CF 患者 LCI 的短期影响,以解决在将 MBW 引入 CF 临床管理时是否必须考虑 PT 和 MBW 的标准化时间的问题。32 名 CF 患者中的 27 名(5.7-15.9 岁)成功地使用 EasyOne Pro、MBW 模块(ndd,瑞士)进行了两次技术上可接受的 MBW 测试,两次测试的间隔为 1(1/2)小时。27 名患者中有 16 名在两次测试之间接受了 30 分钟的 PT,而 11/27 名患者没有接受 PT。PT 前的个体内变异系数(CV)表示为 6.1%,PT 后为 6.5%。两次测试之间 LCI 的平均差异(95%CI)为-0.20(-0.51;0.11)。(SD)为 4.6%(3.1)。无干预时的重复性为 4.2%和 7.1%。第一次和第二次测试之间 LCI 的平均差异(95%CI)为 0.07(-0.22;0.35)。(SD)为 2.6%(2.1)。总之,PT 对 LCI 没有一致的影响。重复性略低于健康受试者的发表值,这可能反映了 CF 患者可变的黏液堵塞,从而导致可变的被困空气。再现性良好且不受干预影响。根据我们的数据,我们得出结论,在设计研究方案或解释纵向数据和治疗效果时,可以忽略 MBW 与 PT 的时间关系。